STOCK TITAN
  1. Home
  2. Sec-filings
  3. MESO
  4. [Form 3] MESOBLAST LTD Initial Statement of Beneficial Ownership

Mesoblast (NASDAQ: MESO) director Cobley details shares and 200,000 options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Mesoblast Ltd director Lynette Elizabeth Cobley filed an initial Form 3 showing her existing equity stake. She reports 30,000 Ordinary Shares held directly and 33,000 Ordinary Shares held indirectly through Synergy Finance Pty Ltd as trustee for her self-managed superannuation fund. She also holds an option over 200,000 Ordinary Shares at an exercise price of $1.72 per share, expiring on May 9, 2032. According to the footnote, these options were granted on May 10, 2025 and vest in three annual tranches through 2028.

Positive

  • None.

Negative

  • None.
Insider COBLEY LYNETTE ELIZABETH
Role null
Type Security Shares Price Value
holding Option (right to buy) -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Option (right to buy) — 200,000 shares (Direct, null); Ordinary Shares — 30,000 shares (Direct, null); Ordinary Shares — 33,000 shares (Indirect, By Synergy Finance Pty Ltd as trustee for Ms Cobley's self-managed superannuation fund.)
Footnotes (1)
  1. [object Object]
Direct Ordinary Shares 30,000 shares Direct ownership reported on Form 3
Indirect Ordinary Shares 33,000 shares Held via Synergy Finance Pty Ltd as trustee
Options underlying shares 200,000 shares Underlying Ordinary Shares for reported option holding
Option exercise price $1.72 per share Exercise price of Option (right to buy)
Option expiration May 9, 2032 Expiration date of Option (right to buy)
First vesting tranche 66,667 options Vest on May 10, 2026
Second vesting tranche 66,667 options Vest on May 10, 2027
Final vesting tranche 66,666 options Vest on May 10, 2028
Form 3 regulatory
"Lynette Elizabeth Cobley filed an initial Form 3 showing her existing equity stake."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
self-managed superannuation fund financial
"held indirectly through Synergy Finance Pty Ltd as trustee for her self-managed superannuation fund."
Option (right to buy financial
"She also holds an option over 200,000 Ordinary Shares at an exercise price"
vesting financial
"these options were granted on May 10, 2025 and vest in three annual tranches"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
COBLEY LYNETTE ELIZABETH
(Last)(First)(Middle)
LEVEL 38
55 COLLINS STREET
(Street)
MELBOURNE, VICTORIA3000
(City)(State)(Zip)
AUSTRALIA
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026		3. Issuer Name and Ticker or Trading Symbol
MESOBLAST LTD [ MESO ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares30,000D
Ordinary Shares33,000IBy Synergy Finance Pty Ltd as trustee for Ms Cobley's self-managed superannuation fund.
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (right to buy) (1)05/09/2032Ordinary Shares200,000$1.72D
Explanation of Responses:
1. Granted on May 10, 2025. 66,667 options will vest on May 10, 2026, 66,667 options will vest on May 10, 2027, and 66,666 options will vest on May 10, 2028.
Remarks:
There are no derivative securities beneficially owned.
/s/ Lynette Elizabeth Cobley04/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does the Mesoblast (MESO) Form 3 filed by Lynette Cobley show?

The Form 3 shows Lynette Cobley’s existing Mesoblast holdings. She reports 30,000 Ordinary Shares directly, 33,000 Ordinary Shares indirectly via a superannuation trust, and an option over 200,000 Ordinary Shares at a $1.72 exercise price expiring in 2032.

How many Mesoblast (MESO) shares does Lynette Cobley hold directly and indirectly?

Lynette Cobley reports 30,000 Mesoblast Ordinary Shares held directly and 33,000 Ordinary Shares held indirectly. The indirect position is held by Synergy Finance Pty Ltd as trustee for her self-managed superannuation fund, reflecting personal retirement-related ownership.

What options over Mesoblast (MESO) shares does Lynette Cobley report on Form 3?

She reports an option over 200,000 Mesoblast Ordinary Shares with a $1.72 exercise price per share and a May 9, 2032 expiration date. The option represents a right to buy future shares if vesting and exercise conditions are met.

What is the vesting schedule of Lynette Cobley’s Mesoblast (MESO) options?

The footnote states the option was granted May 10, 2025 and vests in three tranches: 66,667 options vest May 10, 2026; another 66,667 vest May 10, 2027; and 66,666 vest May 10, 2028, subject to the grant’s terms.

How are Lynette Cobley’s indirect Mesoblast (MESO) holdings structured?

Her 33,000 indirectly held Ordinary Shares are owned by Synergy Finance Pty Ltd as trustee for her self-managed superannuation fund. This structure means the shares are held within a retirement-focused trust rather than directly in her personal name.

Does the Mesoblast (MESO) Form 3 show any recent buy or sell transactions by Lynette Cobley?

The Form 3 presents Cobley’s beneficial ownership as of becoming a reporting person and categorizes the entries as holdings. The transaction summary shows no buy or sell transactions, only three holding entries and a neutral net buy/sell direction.